Custom Search
Ropinirole News
Restless Leg Syndrome drug, REQUIP®, approved by FDA
The US FDA has approved Requip® (ropinirole HCl) Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS) in adults, GlaxoSmithKline announced today. Requip is the first and only FDA-approved treatment...
Baldness Induced By Dopamine Treatments May Be Reversible
Two women with Parkinson's disease who developed alopecia (baldness) while being treated with the dopamine agonists pramipexole or ropinirole found that the hair loss stopped after the drugs were discontinued and replaced with a...
Displaying results 11 to 12 out of 12